ArticleCancer reports (Hoboken, N.J.)2022

Real-world experience of nivolumab in the treatment of poor performance status patients with advanced non-small cell lung cancer.

M Nazim Abbas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.